Deep Longevity
Developing explainable artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
$3.8m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Deep Longevity is a biotechnology company that operates in the longevity and artificial intelligence sector. The company has developed a portfolio of "aging clocks", which are deep learning-based biomarkers of aging. These clocks can analyze data from various sources, including blood tests, DNA, and even psychological surveys, to provide a comprehensive picture of an individual's biological age.
The company's business model is primarily B2B, offering its technology as a service to other businesses. Its main product is the SenoClock SaaS platform, which provides access to all its aging clocks and longevity recommendations. This allows businesses in the healthcare, insurance, and wellness industries to integrate Deep Longevity's aging clock APIs into their own websites and applications. By doing so, they can offer their customers personalized health insights and recommendations for diet, exercise, and lifestyle to promote preventive care and early interventions.
Deep Longevity also engages in longevity R&D, using its AI-discovered biomarkers to advance research in the field. The company collaborates with various partners to further develop and validate its aging clocks. The company's revenue is generated through subscriptions to its SaaS platform and licensing of its API.
Keywords: longevity, artificial intelligence, biotechnology, aging clocks, biomarkers, SaaS, preventive care, personalized health, deep learning, API